• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 Caco-2 细胞模型评价含长链脂质的自乳化制剂的细胞毒性:与中链脂质相比,具有更好的安全性特征。

Evaluation of Cytotoxicity of Self-Emulsifying Formulations Containing Long-Chain Lipids Using Caco-2 Cell Model: Superior Safety Profile Compared to Medium-Chain Lipids.

机构信息

College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Pkwy, Queens, New York 11439.

College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Pkwy, Queens, New York 11439.

出版信息

J Pharm Sci. 2020 May;109(5):1752-1764. doi: 10.1016/j.xphs.2020.01.031. Epub 2020 Feb 7.

DOI:10.1016/j.xphs.2020.01.031
PMID:32035926
Abstract

Medium-chain (MC) and long-chain (LC) lipids are used for development of self-emulsifying drug delivery systems (SEDDS). MC lipids are often preferred because of their ability to form stable microemulsions with relatively high drug solubilization capacity. On the other hand, LC lipids could be more biocompatible as most endogenous and dietary lipids are LC glycerides. They also maintain high drug solubilization capacity after digestion. The present study was undertaken to determine the cytotoxicity of LC lipids and their formulations on Caco-2 cells of 1-day, 5-day, and 21-day maturity. The results were compared with the cytotoxicity profiles of MC lipids reported previously from our laboratory. The cell viability and cell membrane integrity were, respectively, determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and the lactate dehydrogenase assay. The cytotoxicity was partially due to lipid surfactant-induced membrane rupture, and it was influenced by cell maturity and formulation composition. The lipid-surfactant combinations showed greater tolerance than surfactants alone, and LC-SEDDS were well-tolerated at almost 10-fold higher concentration than corresponding MC-SEDDS. Furthermore, the cytotoxicity of digestion end products of both LC and MC triglycerides in the presence of 3 mM sodium taurocholate was compared on 21-day Caco-2 cultures by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The LC lipid formulations showed better tolerance than MC lipid formulations after digestion. Thus, although MC and LC lipids are well-tolerated at doses normally administered to humans, LC lipids show much better safety than MC lipids in a cell-culture model.

摘要

中链(MC)和长链(LC)脂质用于开发自乳化药物传递系统(SEDDS)。由于 MC 脂质能够与相对较高的药物溶解度形成稳定的微乳液,因此常被优先选用。另一方面,LC 脂质可能更具生物相容性,因为大多数内源性和膳食脂质都是 LC 甘油酯。它们在消化后也能保持较高的药物溶解度。本研究旨在确定 LC 脂质及其制剂对 1 天、5 天和 21 天成熟的 Caco-2 细胞的细胞毒性。将结果与我们实验室先前报道的 MC 脂质的细胞毒性谱进行比较。使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐测定法和乳酸脱氢酶测定法分别测定细胞活力和细胞膜完整性。细胞毒性部分归因于脂质表面活性剂诱导的膜破裂,并且受细胞成熟度和制剂组成的影响。脂质-表面活性剂组合的耐受性大于单独的表面活性剂,LC-SEDDS 的耐受性比相应的 MC-SEDDS 高近 10 倍。此外,通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐测定法比较了在存在 3mM 牛磺胆酸钠的情况下,LC 和 MC 甘油三酯的消化终产物在 21 天 Caco-2 培养物中的细胞毒性。LC 脂质制剂在消化后显示出比 MC 脂质制剂更好的耐受性。因此,尽管 MC 和 LC 脂质在通常给予人类的剂量下具有良好的耐受性,但在细胞培养模型中,LC 脂质比 MC 脂质具有更好的安全性。

相似文献

1
Evaluation of Cytotoxicity of Self-Emulsifying Formulations Containing Long-Chain Lipids Using Caco-2 Cell Model: Superior Safety Profile Compared to Medium-Chain Lipids.采用 Caco-2 细胞模型评价含长链脂质的自乳化制剂的细胞毒性:与中链脂质相比,具有更好的安全性特征。
J Pharm Sci. 2020 May;109(5):1752-1764. doi: 10.1016/j.xphs.2020.01.031. Epub 2020 Feb 7.
2
Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.采用Caco-2细胞模型评估含聚氧乙烯蓖麻油EL作为表面活性剂的脂质基自乳化药物递送系统的细胞毒性
Eur J Pharm Sci. 2016 Aug 25;91:162-71. doi: 10.1016/j.ejps.2016.06.011. Epub 2016 Jun 17.
3
Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.使用Caco-2细胞模型评估基于脂质的自乳化药物递送系统存在下的细胞活力和渗透增强:以聚山梨酯80作为表面活性剂。
Eur J Pharm Sci. 2017 Mar 1;99:350-360. doi: 10.1016/j.ejps.2016.12.018. Epub 2016 Dec 24.
4
Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.用于口服依诺肝素给药的自乳化药物递送系统(SEDDS)的开发、体外和体内评价。
Eur J Pharm Biopharm. 2016 Dec;109:113-121. doi: 10.1016/j.ejpb.2016.09.013. Epub 2016 Sep 28.
5
Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?自乳化药物传递系统和阳离子表面活性剂:它们在细胞毒性方面是否相互增效?
J Pharm Pharmacol. 2019 Feb;71(2):156-166. doi: 10.1111/jphp.13021. Epub 2018 Sep 25.
6
Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility: Formulation and dispersion testing.利用长链甘油三酯消化产物开发用于高药物溶解度的基于脂质的 SEDDS:配方和分散测试。
Int J Pharm. 2024 Apr 10;654:123953. doi: 10.1016/j.ijpharm.2024.123953. Epub 2024 Feb 27.
7
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.脂质消化作为过饱和的触发因素:评价过饱和度稳定对自乳化药物传递系统的体内外性能的影响。
Mol Pharm. 2012 Jul 2;9(7):2063-79. doi: 10.1021/mp300164u. Epub 2012 Jun 15.
8
Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.槲皮素新型自乳化制剂增强体内抗氧化潜力:对药物诱导的心脏毒性和肾毒性的影响。
Free Radic Biol Med. 2013 Dec;65:117-130. doi: 10.1016/j.freeradbiomed.2013.05.041. Epub 2013 Jun 19.
9
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.将 CETP 抑制剂 CP-532,623 的脂质体制剂的体外溶解和超饱和度曲线与体内暴露相关联。
Mol Pharm. 2017 Dec 4;14(12):4525-4538. doi: 10.1021/acs.molpharmaceut.7b00660. Epub 2017 Nov 9.
10
In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.采用分散和消化试验对无药物和非诺贝特载脂体制剂进行体外评估,可深入了解制剂在肠道中的可能命运。
Eur J Pharm Sci. 2013 Jul 16;49(4):748-60. doi: 10.1016/j.ejps.2013.04.036. Epub 2013 May 16.

引用本文的文献

1
Hydrophobic ion pairing: lipophilicity improvement of anionic macromolecules by divalent cation mediated complex formation.疏水离子对:通过二价阳离子介导的复合物形成提高阴离子大分子的亲脂性
Drug Deliv Transl Res. 2024 Dec 17. doi: 10.1007/s13346-024-01760-1.
2
Preparation and Evaluation of Nanoemulsion Formulation Containing Kojic Acid and Kojyl 3-aminopropylphosphonic Acid.含曲酸和曲酸3-氨丙基膦酸的纳米乳剂配方的制备与评价
Curr Pharm Biotechnol. 2025;26(4):608-616. doi: 10.2174/0113892010310230240615112928.
3
Effect of Digested Selected Food Items on Markers of Oxidative Stress and Inflammation in a Caco-2-Based Human Gut Epithelial Model.
在基于Caco-2的人肠道上皮模型中,消化后的特定食物对氧化应激和炎症标志物的影响。
Antioxidants (Basel). 2024 Jan 25;13(2):150. doi: 10.3390/antiox13020150.
4
Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.肽抗生素-多聚磷酸盐纳米颗粒:克服肠道酶和黏液屏障的一种有前途的策略。
Biomacromolecules. 2023 Jun 12;24(6):2587-2595. doi: 10.1021/acs.biomac.3c00083. Epub 2023 May 24.
5
Using a Cellular System to Directly Assess the Effects of Cosmetic Microemulsion Encapsulated DeoxyArbutin.利用细胞系统直接评估包裹脱氧熊果苷的化妆品微乳液的效果。
Int J Mol Sci. 2021 Dec 3;22(23):13110. doi: 10.3390/ijms222313110.
6
Dual-Acting Zeta-Potential-Changing Micelles for Optimal Mucus Diffusion and Enhanced Cellular Uptake after Oral Delivery.用于口服给药后实现最佳黏液扩散和增强细胞摄取的双功能ζ电位变化胶束。
Pharmaceutics. 2021 Jun 27;13(7):974. doi: 10.3390/pharmaceutics13070974.
7
Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.通过负载 Cubosomal 凝胶的鼻腔递送来实现盐酸度洛西汀的脑靶向:体外特性分析、体外渗透和体内生物分布研究。
Int J Nanomedicine. 2020 Nov 30;15:9517-9537. doi: 10.2147/IJN.S277352. eCollection 2020.
8
Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery.自纳米乳化药物递送系统:从开发到口服药物递送的当前应用与挑战
Pharmaceutics. 2020 Dec 9;12(12):1194. doi: 10.3390/pharmaceutics12121194.